Journal article
Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada
Abstract
ObjectivesIntravenous immunoglobulin (IVIG) has demonstrated improvement in chronic inflammatory demyelinating polyneuropathy (CIDP) patients in placebo controlled trials. However, IVIG is also much more expensive than alternative treatments such as corticosteroids. The objective of the paper is to evaluate, from a Canadian perspective, the cost-effectiveness of IVIG compared to corticosteroid treatment of CIDP.MethodsA markov model was used to …
Authors
Blackhouse G; Gaebel K; Xie F; Campbell K; Assasi N; Tarride J-E; O'Reilly D; Chalk C; Levine M; Goeree R
Journal
Cost Effectiveness and Resource Allocation, Vol. 8, No. 1,
Publisher
Springer Nature
Publication Date
2010
DOI
10.1186/1478-7547-8-14
ISSN
1478-7547